Re-Treatment of Relapsed Paget's Disease of Bone With Zoledronic Acid: Results From an Open-Label Study

BoneKEy Reports

doi 10.1038/bonekey.2013.176

Full Text

Abstract

Available in

Date

Authors

Publisher

Portico

Related search

Treatment of Paget's Disease of Bone

BMJ
1988English

Ibrutinib as Treatment for Patients With Relapsed/Refractory Follicular Lymphoma: Results From the Open-Label, Multicenter, Phase II DAWN Study

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2018English

Paget's Disease of Bone

Postgraduate Medical Journal
Medicine
1970English

A Family Study of Paget's Disease of Bone.

Journal of Epidemiology and Community Health
EpidemiologyPublic HealthOccupational HealthEnvironmental
1983English

Life-Threatening Hyperkalemia Following Zoledronic Acid Infusion for Paget's Disease: A Case Report

Journal of Medical Case Reports
Medicine
2011English

Paget's Disease of Bone--A Clinical and Genetic Study.

Postgraduate Medical Journal
Medicine
1977English

Long-Term Metformin Treatment in Adolescents With Obesity and Insulin Resistance, Results of an Open Label Extension Study

Nutrition and Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

Paget's Disease in Temporal Bone

2018English

Enduring Efficacy and Tolerability of Daratumumab in Combination With Lenalidomide and Dexamethasone in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma ( GEN 503): Final Results of an Open‐label, Phase 1/2 Study

British Journal of Haematology
Hematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy